2027 Future Talent Program - Clinical and Regulatory Strategic Communications - Intern

Job Description

The Future Talent Program features internships that last up to 12 weeks and will include one or more projects. These opportunities in our Research Labs Division can provide you with great development and a chance to see if we are the right company for your long-term goals. Seeking a highly motivated individual who is pursuing an education in the life sciences, medicine, pharmacology/pharmacy, quality, operations, data science, or a related field, and who is interested in writing, communicating about medicine and science, and supporting the quality, compliance and operational excellence activities that enable clinical research. The goal of this position is for the individual to gain broad insight into the following: The roles of several types of medical writers at a large pharmaceutical company The drug development process Documents needed to conduct clinical trials and gain approval for new medicines Informed consent Disclosure of clinical trial information to the public Health literacy and plain language concepts Quality, compliance, operational excellence, that support clinical research execution Clinical Regulatory & Strategic Communications (CRSC) is a multidisciplinary organization that plays a critical role in supporting the development of new medicines by creating key clinical and regulatory documents, communicating clinical trial results, and ensuring information is shared responsibly and transparently with regulatory agencies, healthcare professionals, trial participants, and the public. The department develops and manages essential clinical trial documents, including study protocols, informed consent forms, investigator brochures, clinical study reports, and regulatory summaries. CRSC also supports public disclosure activities by creating technical and plain-language summaries of clinical trial information and results. We also drive quality, compliance, continuous improvement, and adoption of innovative technologies, including artificial in